Arcadia Biosciences Sees Surge in Short Interest

Biotech firm's stock faces increased bearish bets amid market volatility

Published on Mar. 3, 2026

Got story updates? Submit your updates here. ›

Arcadia Biosciences, Inc., an agricultural biotechnology company based in Davis, California, saw a 45.4% increase in short interest on its stock during the month of February. As of February 13th, 15,855 shares were sold short, representing 1.0% of the company's total outstanding shares.

Why it matters

The rise in short interest suggests increased bearish sentiment among investors towards Arcadia Biosciences, likely due to broader market volatility and uncertainty around the company's long-term prospects. This could signal potential challenges ahead for the firm as it seeks to develop and commercialize its crop trait and food ingredient technologies.

The details

Arcadia Biosciences, founded in 2002, focuses on developing non-transgenic agricultural products that promote health and sustainability. The company operates in two main business segments: Crop Traits and Food Ingredients. According to data from MarketBeat.com, one equity research analyst has a 'Sell' rating on Arcadia's stock.

  • As of February 13th, 2026, there was short interest totaling 15,855 shares.
  • This represented a 45.4% increase from the January 29th total of 10,905 shares.

The players

Arcadia Biosciences, Inc.

An agricultural biotechnology company headquartered in Davis, California, that develops non-transgenic crop traits and food ingredients.

Weiss Ratings

A research firm that recently maintained a 'sell (d-)' rating on Arcadia Biosciences' stock.

Got photos? Submit your photos here. ›

What they’re saying

“We must not let individuals continue to damage private property in San Francisco.”

— Robert Jenkins, San Francisco resident (San Francisco Chronicle)

The takeaway

The surge in short interest on Arcadia Biosciences' stock suggests growing skepticism among investors about the company's long-term prospects, potentially driven by broader market volatility and uncertainty. This could signal challenges ahead as Arcadia seeks to commercialize its innovative agricultural technologies.